Violation Tracker Individual Record
Company:US Bioservices Corp.
Date:August 23, 2017
Offense Group:government-contracting-related offenses
Primary Offense:False Claims Act and related
Secondary Offense:kickbacks and bribery
The settlement resolved claims that US Bioservices violated the Anti-Kickback Statute and the False Claims Act by participating in a kickback scheme with Novartis Pharmaceuticals Corp. relating to the latter's drug Exjade.
Level of Government:federal
Action Type:agency action
Agency:U.S. Attorney-Southern District of New York
Civil or Criminal Case:civil
HQ Country of Parent:USA
HQ State of Parent:Pennsylvania
Ownership Structure of Parent:publicly traded
Major Industry of Parent:wholesalers
Specific Industry of Parent:wholesalers-pharmaceuticals
Source Notes:If an online information source is not working, check the Violation Tracker Data Sources page for an updated link.